Sanofi-Aventis, the French pharmaceutical company, owns the trademark ACOMPLIA for the anti-obesity drug rimonabart (not yet approved here).  Medical Week News owns the domain name ACOMPLIAREPORT.COM and publishes news about the drug.  Sanofi filed a UDRP action with WIPO.  Medical Week News, represented by EFF, filed a declaractory jdugment action, complaint here.